{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:48:25Z","timestamp":1791186505434,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.gastrohep.2014.02.001","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T01:04:01Z","timestamp":1395450241000},"page":"262-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Alcoholic hepatitis: Prognosis and treatment"],"prefix":"10.1016","volume":"37","author":[{"given":"Jennifer","family":"Casanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2014.02.001_bib0005","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gut.2010.221382","article-title":"Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years","volume":"60","author":"Roulot","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2011.134","article-title":"Alcoholic liver disease: pathogenesis and new targets for therapy","volume":"8","author":"Altamirano","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0020","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2010.07.016","article-title":"Incidence and mortality of alcoholic hepatitis in Denmark 1999\u20132008: a nationwide population based cohort study","volume":"54","author":"Sandahl","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","article-title":"Excess weight risk factor for alcoholic liver disease","volume":"25","author":"Naveau","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0035","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/00365528309181659","article-title":"The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis","volume":"18","author":"Kryger","year":"1983","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0040","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2011.02.021","article-title":"The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis","volume":"55","author":"Mookerjee","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0060","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0065","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0075","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0080","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0085","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-74-3-311","article-title":"Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy","volume":"74","author":"Helman","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0120","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis\u2014a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hep.23666","article-title":"Theophylline improves steroid sensitivity in acute alcoholic hepatitis","volume":"52","author":"Kendrick","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0140","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0145","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.1613","article-title":"Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial","volume":"15","author":"De","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0150","first-page":"CD007339","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0155","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","article-title":"Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity","volume":"132","author":"Colmenero","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0160","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0170","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0175","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0185","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0016-5085(01)83918-4","article-title":"Nutritional therapy for alcoholic hepatitis: new life for an old idea","volume":"120","author":"Foody","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0190","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2036.2003.01660.x","article-title":"Nutritional therapy in alcoholic liver disease","volume":"18","author":"Stickel","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 3","key":"10.1016\/j.gastrohep.2014.02.001_bib0195","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1111\/j.1440-1746.2006.04575.x","article-title":"Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver disease","volume":"21","author":"Lu","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0200","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0205","first-page":"CD002235","article-title":"S-adenosyl-l-methionine for alcoholic liver diseases","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-6143.2009.02869.x","article-title":"Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry)","volume":"10","author":"Burra","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0215","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bpg.2010.07.003","article-title":"Alcoholic steatohepatitis","volume":"24","author":"Stickel","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0220","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2009.12.021","article-title":"The place of liver transplantation in the treatment of severe alcoholic hepatitis","volume":"52","author":"Dureja","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0225","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1572-0241.2002.05826.x","article-title":"Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review","volume":"97","author":"Rambaldi","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0230","first-page":"CD002800","article-title":"Propylthiouracil for alcoholic liver disease","author":"Fede","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"28","author":"Pares","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0245","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40263-013-0043-4","article-title":"Management of alcohol dependence in patients with liver disease","volume":"27","author":"Addolorato","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0255","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2174\/138161210791516431","article-title":"Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment","volume":"16","author":"Krampe","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0260","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0168-8278(94)80249-1","article-title":"Disulfiram-induced hepatitis. Report of four cases and review of the literature","volume":"21","author":"Forns","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0265","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1056\/NEJMct0801733","article-title":"Naltrexone for the management of alcohol dependence","volume":"359","author":"Anton","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0270","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0275","first-page":"CD004332","article-title":"Acamprosate for alcohol dependence","author":"Rosner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0280","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/13543780902905855","article-title":"The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data","volume":"18","author":"Addolorato","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0285","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.gastrohep.2014.02.001_bib0290","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570514000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570514000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T16:22:03Z","timestamp":1565281323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570514000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0210570514000466"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2014.02.001","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcoholic hepatitis: Prognosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2014.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L. and AEEH y AEG. All rights reserved.","name":"copyright","label":"Copyright"}]}}